Dermal and Gynecological Acceptability (Irritability and Sensitization in the Genital Mucosa) of an Investigational Product and Evaluation of Moisture Efficacy by TEWL and Perceived Efficacy. (DERM GYN ACCEP)

December 29, 2016 updated by: Kley Hertz S/A
To evaluate the safety of an investigational product through the verification of signs of irritability and sensitization of the genital mucosa, as well as the instrumental moisturizing efficacy by TEWL and barrier integrity analysis, in addition to the efficacy perceived by the volunteers.

Study Overview

Status

Unknown

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

33

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Healthy female sex with active sex life;
  • Age group: between 45 and 65 years old;
  • Menopause for at least six months;
  • Whole skin in the region of product analysis;
  • No history of reaction to products of the same category
  • Understanding, agreement and signature of the Term of Free and Informed Consent.

Exclusion Criteria:

  • Gestation or risk of gestation;
  • Use of anti-inflammatory / immunosuppressive drugs (in the last 30 days and during the study);
  • Active cutaneous pathologies (local and / or disseminated) in the evaluation area;
  • Pathologies that cause suppression of immunity, such as diabetes, HIV, etc.;
  • Endocrine pathologies such as thyroid disorders, ovarian or adrenal gland disorders;
  • Any infection in the region of analysis of the product diagnosed at the time of inclusion;
  • Other conditions considered by the investigating physician as reasonable for disqualification of the individual from the study participation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Evaluation of the product's efficiency as a moisturizer through subjective evaluation
Time Frame: 30 days
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2017

Primary Completion (Anticipated)

February 1, 2017

Study Registration Dates

First Submitted

December 29, 2016

First Submitted That Met QC Criteria

December 29, 2016

First Posted (Estimate)

January 2, 2017

Study Record Updates

Last Update Posted (Estimate)

January 2, 2017

Last Update Submitted That Met QC Criteria

December 29, 2016

Last Verified

December 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • Kley Hertz 007

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Female Dry Genital Mucosa

Clinical Trials on Intimate Lubricant Gel

3
Subscribe